IOPE BRIGHTGEN (AMOREPACIFIC)


Welcome to the PulseAid listing for the IOPE BRIGHTGEN drug offered from AMOREPACIFIC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: AMOREPACIFIC
NON-PROPRIETARY NAME: OXYBENZONE, OCTINOXATE, OCTISALATE, HOMOSALATE, OCTOCRYLENE, and TITANIUM DIOXIDE
SUBSTANCE NAME: OXYBENZONE; OCTINOXATE; OCTISALATE; HOMOSALATE; OCTOCRYLENE; TITANIUM DIOXIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2012-08-24
END MARKETING DATE: 0000-00-00


IOPE BRIGHTGEN HUMAN OTC DRUG Details:

Item DescriptionIOPE BRIGHTGEN from AMOREPACIFIC
LABELER NAME: AMOREPACIFIC
DEA SCHEDULE:
ACTIVE STRENGTH: 2.7; 4.2; 2.7; 3; 3; 3.12(g/60mL; g/60mL; g/60mL; g/60mL; g/60mL; g/60mL)
START MARKETING DATE: 2012-08-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43419-330_f3df54e7-44b5-403a-ac57-a7d2030fc009
PRODUCT NDC: 43419-330
APPLICATION NUMBER: part352

Other OXYBENZONE; OCTINOXATE; OCTISALATE; HOMOSALATE; OCTOCRYLENE; TITANIUM DIOXIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AMOREPACIFICIOPE BRIGHTGEN